Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration

European Journal of Heart Failure

Volumn 10, Issue 6, 2008, Pages 581-586

  Oldenburg, Olaf ^a   Schmidt, Anke ^b   Lamp, Barbara ^a   Bitter, Thomas ^a   Muntean, Bogdan G ^a   Langer, Christoph ^a   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Cardiac Research Unit   (Germany)

Author keywords

Adaptive servoventilation; Cheyne Stokes respiration; Chronic heart failure; Sleep disordered breathing

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY EXERCISE TEST; CHEYNE STOKES BREATHING; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; WORKLOAD;

AGED; CHEYNE-STOKES RESPIRATION; COHORT STUDIES; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSITIVE-PRESSURE RESPIRATION; REGISTRIES; RETROSPECTIVE STUDIES; SLEEP APNEA SYNDROMES; STROKE VOLUME;

EID: 44649136713     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.04.007     Document Type: Article

References (30)

1. Oldenburg O., Lamp B., Faber L., Teschler H., Horstkotte D., and Töpfer V. Sleep disordered breathing in patients with symptomatic heart failure. Eur J Heart Fail 9 (2007) 251-257
2. Arzt M., and Bradley T. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 173 (2006) 1300-1308
3. Arzt M., Floras J., Logan A., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. Circulation 115 (2007) 3173-3180
4. Lanfranchi P., Somers V., Braghiroli A., Corra U., Eleuteri E., and Giannuzzi P. Central sleep apnea in left ventricular dysfunction. Prevalence and implications for arrhythmic risk. Circulation 107 (2003) 727-732
5. Sin D., Logan A., Fitzgerald F., Liu P., and Bradley T. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102 (2000) 61-66
6. Sinha A., Skobel E., Breithardt O., et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44 (2004) 68-71
7. Oldenburg O., Faber L., Vogt J., et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9 (2007) 820-826
8. Tamura A., Kawano Y., Naono S., Kotoku M., and Kadota J. Relationship between b-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131 (2007) 130-135
9. Bradley T., Logan A., Kimoff R., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
10. Philippe C., Stoica-Herman M., Drouot X., et al. Compliance with and efficacy of adaptive servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92 (2006) 337-342
11. Teramoto S., and Ouchi Y. Clinical significance of arterial blood gas analysis for detection and/or treatment of central sleep apnea in patients with heart failure. Circulation 99 (1999) 2702-2712
12. Teschler H., Döhring J., Wang Y.M., and Berthon-Jones M. Adaptive pressure support servo-ventilation. A novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164 (2001) 614-619
13. Oldenburg O., Lamp B., and Horstkotte D. Cardiorespiratory screening for sleep-disordered breathing. Eur Respir J 28 (2006) 1065-1067
14. Oldenburg O., Lamp B., Freudenberg G., and Horstkotte D. Screening for sleep disordered breathing is recommended in patients with chronic heart failure. Eur Respir J 30 (2007) 1023
15. Zhang X., Yin K., Li X., Jia E., and Su M. Efficacy of adaptive servoventilation in patients with congestive heart failure and Cheyne-Stokes respiration. Chin Med J 119 (2006) 622-627
16. Kasai T., Narui K., Dohi T., et al. First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure. Circ J 70 (2006) 1148-1154
17. Pepperell J., Maskell N., Jones D., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168 (2003) 1109-1114
18. Schädlich S., Königs I., Kalbitz F., Blankenburg T., Busse H., and Schütte W. Kardiale Leistungsfähigkeit bei Patienten mit Cheyne-Stokes-Atmung infolge Herzinsuffizienz während langfristiger Beatmungstherapie mittels adaptiver Servoventilation (AutoSet CS®). Z Kardiol 93 (2004) 454-462
19. Jourdain P., Jondeau G., Funck R., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J Am Coll Cardiol 49 (2007) 1733-1739
20. Groenning B., Raymond I., Hildebrand P., Nilsson J., Baumann M., and Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 90 (2004) 297-303
21. Gardner R., Özalp F., Murday A., Robb S., and McDonagh T. N-terminal pro-brain natriuretic peptide. Eur Heart J 24 (2003) 1735-1743
22. Miller W., Hartman K., Burritt M., et al. Serial biomarker measurements in ambulatory patients with chronic heart failure. The importance of change over time. Circulation 116 (2007) 249-257
23. Seifert M., Schlegl M., Hoersch W., et al. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121 (2007) 68-73
24. Frühwald F., Fahrleitner-Pammer A., Berger R., et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28 (2007) 1592-1597
25. Olsen S., Gilbert E., Renlund D., Taylor D., Yanowitz F., and Bristow M. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 25 (1995) 1225-1231
26. Hole T., Frøland G., Gullestad L., Offstad J., and Skjaerpe T. Motoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure. Echocardiography 21 (2004) 215-223
27. Pires L., Abraham W., Young J., and Johnson K. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trails. Am Heart J 151 (2006) 837-847
28. Gustafsson F., Torp-Pedersen C., Brendorp B., Seibæk M., Burchardt H., and Køber L. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24 (2003) 863-870
29. Solomon S., Anavekar N., Skali H., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (2005) 3738-3744
30. Abraham W., Fisher W., Smith A., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853